291 related articles for article (PubMed ID: 25972230)
41. Do genetic modifiers of high-density lipoprotein cholesterol and triglyceride levels also modify their response to a lifestyle intervention in the setting of obesity and type-2 diabetes mellitus?: The Action for Health in Diabetes (Look AHEAD) study.
Huggins GS; Papandonatos GD; Erar B; Belalcazar LM; Brautbar A; Ballantyne C; Kitabchi AE; Wagenknecht LE; Knowler WC; Pownall HJ; Wing RR; Peter I; McCaffery JM;
Circ Cardiovasc Genet; 2013 Aug; 6(4):391-9. PubMed ID: 23861364
[TBL] [Abstract][Full Text] [Related]
42. Analysis of a cardiovascular disease genetic risk score in the Diabetes Heart Study.
Raffield LM; Cox AJ; Carr JJ; Freedman BI; Hicks PJ; Langefeld CD; Hsu FC; Bowden DW
Acta Diabetol; 2015 Aug; 52(4):743-51. PubMed ID: 25700702
[TBL] [Abstract][Full Text] [Related]
43. [Lifestyle-recommendations on weight loss in type 2 diabetes--useful, or not?].
Admiraal WM; Holleman F; Hoekstra JB
Ned Tijdschr Geneeskd; 2013; 157(43):A6813. PubMed ID: 24152367
[TBL] [Abstract][Full Text] [Related]
44. Impact of the look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes.
Bertoni AG; Wagenknecht LE; Kitzman DW; Marcovina SM; Rushing JT; Espeland MA;
Obesity (Silver Spring); 2012 Jul; 20(7):1511-8. PubMed ID: 21959345
[TBL] [Abstract][Full Text] [Related]
45. Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the Look AHEAD trial.
Baum A; Scarpa J; Bruzelius E; Tamler R; Basu S; Faghmous J
Lancet Diabetes Endocrinol; 2017 Oct; 5(10):808-815. PubMed ID: 28711469
[TBL] [Abstract][Full Text] [Related]
46. Lifestyle intervention and/or statins for the reduction of C-reactive protein in type 2 diabetes: from the look AHEAD study.
Belalcazar LM; Haffner SM; Lang W; Hoogeveen RC; Rushing J; Schwenke DC; Tracy RP; Pi-Sunyer FX; Kriska AM; Ballantyne CM;
Obesity (Silver Spring); 2013 May; 21(5):944-50. PubMed ID: 23512860
[TBL] [Abstract][Full Text] [Related]
47. Change in Cardiometabolic Risk Factors Associated With Magnitude of Weight Regain 3 Years After a 1-Year Intensive Lifestyle Intervention in Type 2 Diabetes Mellitus: The Look AHEAD Trial.
Berger SE; Huggins GS; McCaffery JM; Jacques PF; Lichtenstein AH
J Am Heart Assoc; 2019 Oct; 8(20):e010951. PubMed ID: 31594431
[TBL] [Abstract][Full Text] [Related]
48. Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study.
; Bray G; Gregg E; Haffner S; Pi-Sunyer XF; WagenKnecht LE; Walkup M; Wing R
Diab Vasc Dis Res; 2006 Dec; 3(3):202-15. PubMed ID: 17160917
[TBL] [Abstract][Full Text] [Related]
49. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial.
; Pi-Sunyer X; Blackburn G; Brancati FL; Bray GA; Bright R; Clark JM; Curtis JM; Espeland MA; Foreyt JP; Graves K; Haffner SM; Harrison B; Hill JO; Horton ES; Jakicic J; Jeffery RW; Johnson KC; Kahn S; Kelley DE; Kitabchi AE; Knowler WC; Lewis CE; Maschak-Carey BJ; Montgomery B; Nathan DM; Patricio J; Peters A; Redmon JB; Reeves RS; Ryan DH; Safford M; Van Dorsten B; Wadden TA; Wagenknecht L; Wesche-Thobaben J; Wing RR; Yanovski SZ
Diabetes Care; 2007 Jun; 30(6):1374-83. PubMed ID: 17363746
[TBL] [Abstract][Full Text] [Related]
50. Within and post-trial effects of an intensive lifestyle intervention on kidney disease in adults with overweight or obesity and type 2 diabetes mellitus: a secondary analysis of the Look AHEAD clinical trial.
Knowler WC; Chen H; Bahnson JL; Kahn SE; Lewis CE; Nathan DM; Nelson RG; Pilla SJ; Bantle JP;
BMJ Open Diabetes Res Care; 2024 May; 12(3):. PubMed ID: 38816203
[TBL] [Abstract][Full Text] [Related]
51. Waist Circumference Change During Intensive Lifestyle Intervention and Cardiovascular Morbidity and Mortality in the Look AHEAD Trial.
Olson KL; Neiberg RH; Espeland MA; Johnson KC; Knowler WC; Pi-Sunyer X; Staiano AE; Wagenknecht LE; Wing RR;
Obesity (Silver Spring); 2020 Oct; 28(10):1902-1911. PubMed ID: 32881403
[TBL] [Abstract][Full Text] [Related]
52. Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial.
Rubin RR; Wadden TA; Bahnson JL; Blackburn GL; Brancati FL; Bray GA; Coday M; Crow SJ; Curtis JM; Dutton G; Egan C; Evans M; Ewing L; Faulconbridge L; Foreyt J; Gaussoin SA; Gregg EW; Hazuda HP; Hill JO; Horton ES; Hubbard VS; Jakicic JM; Jeffery RW; Johnson KC; Kahn SE; Knowler WC; Lang W; Lewis CE; Montez MG; Murillo A; Nathan DM; Patricio J; Peters A; Pi-Sunyer X; Pownall H; Rejeski WJ; Rosenthal RH; Ruelas V; Toledo K; Van Dorsten B; Vitolins M; Williamson D; Wing RR; Yanovski SZ; Zhang P;
Diabetes Care; 2014 Jun; 37(6):1544-53. PubMed ID: 24855155
[TBL] [Abstract][Full Text] [Related]
53. Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial.
Wing RR; Rosen RC; Fava JL; Bahnson J; Brancati F; Gendrano Iii IN; Kitabchi A; Schneider SH; Wadden TA
J Sex Med; 2010 Jan; 7(1 Pt 1):156-65. PubMed ID: 19694925
[TBL] [Abstract][Full Text] [Related]
54. Intensive lifestyle intervention in type 2 diabetes and risk of incident coronary artery disease for the common haptoglobin phenotypes: the Look AHEAD study.
Warren RA; Bancks MP; Carew AS; Levy AP; Sapp J; Bahnson J; Lewis CE; Rimm EB; Espeland MA; Cahill LE
Cardiovasc Diabetol; 2024 Feb; 23(1):82. PubMed ID: 38402400
[TBL] [Abstract][Full Text] [Related]
55. The Look AHEAD Trial: bone loss at 4-year follow-up in type 2 diabetes.
Lipkin EW; Schwartz AV; Anderson AM; Davis C; Johnson KC; Gregg EW; Bray GA; Berkowitz R; Peters AL; Hodges A; Lewis C; Kahn SE;
Diabetes Care; 2014 Oct; 37(10):2822-9. PubMed ID: 25048381
[TBL] [Abstract][Full Text] [Related]
56. The Association of Prior Intensive Lifestyle Intervention and Diabetes Support and Education With Frailty Prevalence at Long-Term Follow-Up in the Action for Health in Diabetes Extension Study.
Look AHEAD Research Group
J Gerontol A Biol Sci Med Sci; 2022 Oct; 77(10):2040-2049. PubMed ID: 34637524
[TBL] [Abstract][Full Text] [Related]
57. Impact of HDL genetic risk scores on coronary artery calcified plaque and mortality in individuals with type 2 diabetes from the Diabetes Heart Study.
Raffield LM; Cox AJ; Hsu FC; Ng MC; Langefeld CD; Carr JJ; Freedman BI; Bowden DW
Cardiovasc Diabetol; 2013 Jun; 12():95. PubMed ID: 23799899
[TBL] [Abstract][Full Text] [Related]
58. The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE.
Lee AK; Woodward M; Wang D; Ohkuma T; Warren B; Sharrett AR; Williams B; Marre M; Hamet P; Harrap S; Mcevoy JW; Chalmers J; Selvin E
J Clin Endocrinol Metab; 2020 Jan; 105(1):152-62. PubMed ID: 31588504
[TBL] [Abstract][Full Text] [Related]
59. Association of the Intensive Lifestyle Intervention With Total Knee Replacement in the Look AHEAD (Action for Health in Diabetes) Clinical Trial.
Richey PA; Johnson KC; Neiberg RH; Bahnson JL; Singhal K; Coday M; Thomas F; Lewis CE; Mihalko WM;
J Arthroplasty; 2020 Jun; 35(6):1576-1582. PubMed ID: 32085906
[TBL] [Abstract][Full Text] [Related]
60. Obesity genotype score and cardiovascular risk in women with type 2 diabetes mellitus.
He M; Cornelis MC; Franks PW; Zhang C; Hu FB; Qi L
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):327-32. PubMed ID: 19910641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
